Condition | Indicated | Relationship Strength | Studies | Trials |
Cancer of Lung [description not available] | 0 | 2.55 | 2 | 0 |
Lung Neoplasms Tumors or cancer of the LUNG. | 0 | 2.55 | 2 | 0 |
Cognitive Decline [description not available] | 0 | 2.21 | 1 | 0 |
Cerebral Ischemia [description not available] | 0 | 2.21 | 1 | 0 |
Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. | 0 | 2.21 | 1 | 0 |
Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. | 0 | 2.21 | 1 | 0 |
Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. | 0 | 2.1 | 1 | 0 |
Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. | 0 | 2.1 | 1 | 0 |
Acute Confusional Senile Dementia [description not available] | 0 | 2.11 | 1 | 0 |
Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) | 0 | 2.11 | 1 | 0 |
Clinically Isolated CNS Demyelinating Syndrome [description not available] | 0 | 2.11 | 1 | 0 |
Allergic Encephalomyelitis [description not available] | 0 | 2.11 | 1 | 0 |
Innate Inflammatory Response [description not available] | 0 | 3.39 | 2 | 0 |
Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | 0 | 2.11 | 1 | 0 |
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 3.39 | 2 | 0 |
Encephalopathy, Toxic [description not available] | 0 | 2.04 | 1 | 0 |
Degenerative Diseases, Central Nervous System [description not available] | 0 | 2.96 | 1 | 0 |
Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. | 0 | 2.96 | 1 | 0 |
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 2.05 | 1 | 0 |
Lung Adenocarcinoma [description not available] | 0 | 2.07 | 1 | 0 |
Adenocarcinoma, Basal Cell [description not available] | 0 | 2.07 | 1 | 0 |
Adenocarcinoma of Lung A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. | 0 | 2.07 | 1 | 0 |
Adenocarcinoma A malignant epithelial tumor with a glandular organization. | 0 | 2.07 | 1 | 0 |
Idiopathic Parkinson Disease [description not available] | 0 | 3.34 | 2 | 0 |
Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) | 0 | 3.34 | 2 | 0 |
Rheumatoid Arthritis [description not available] | 0 | 3.09 | 5 | 0 |
Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. | 0 | 3.09 | 5 | 0 |
Cancer of Stomach [description not available] | 0 | 2.02 | 1 | 0 |
Stomach Neoplasms Tumors or cancer of the STOMACH. | 0 | 2.02 | 1 | 0 |
Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. | 0 | 2.03 | 1 | 0 |
MPTP Neurotoxicity Syndrome [description not available] | 0 | 2.03 | 1 | 0 |
Weight Gain Increase in BODY WEIGHT over existing weight. | 0 | 1.98 | 1 | 0 |
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2 | 1 | 0 |